Human Papillomavirus-Related Diseases: Oropharynx Cancers and Potential Implications for Adolescent HPV Vaccination

Journal of Adolescent Health

Volumn 43, Issue 4 SUPPL., 2008, Pages

  Gillison, Maura L ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Cancer; Human papillomavirus

Indexed keywords

HUMAN PAPILLOMAVIRUS 16 L1 VIRUS LIKE PARTICLE VACCINE; HUMAN PAPILLOMAVIRUS 18 L1 VIRUS LIKE PARTICLE VACCINE; UNCLASSIFIED DRUG; WART VIRUS VACCINE;

CANCER RISK; CLINICAL TRIAL; HEAD AND NECK CARCINOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; OROPHARYNX CANCER; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEROPREVALENCE; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; VACCINATION; VIRUS TRANSMISSION; WART VIRUS;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADULT; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; INCIDENCE; MALE; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; SEX FACTORS; SEXUAL BEHAVIOR; UNITED STATES;

EID: 52049099715     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2008.07.002     Document Type: Review

References (99)

1. Syrjanen K., Syrjanen S., Lamberg M., et al. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg 12 6 (1983) 418-424
2. Loning T., Ikenberg H., Becker J., et al. Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. J Invest Dermatol 84 5 (1985) 417-420
3. Franceschi S., Munoz N., Bosch X.F., et al. Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev 5 7 (1996) 567-575
4. Niedobitek G., Pitteroff S., Herbst H., et al. Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil. J Clin Pathol 43 11 (1990) 918-921
5. Snijders P.J., Cromme F.V., van den Brule A.J., et al. Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer (1992) 30;51(6):845-50
6. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 20003;92(9):709-20.
7. Ha P.K., Pai S.I., Westra W.H., et al. Real-time quantitative PCR demonstrates low prevalence of human papillomavirus type 16 in premalignant and malignant lesions of the oral cavity. Clin Cancer Res 8 5 (2002) 1203-1209
8. Klussmann J.P., Weissenborn S.J., Wieland U., et al. Human papillomavirus-positive tonsillar carcinomas: a different tumor entity?. Med Microbiol Immunol (Berl) 192 3 (2003) 129-132
9. Klussmann JP, Weissenborn SJ, Wieland U, et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 20011;92(11):2875-84.
10. Mellin H., Dahlgren L., Munck-Wikland E., et al. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 102 2 (2002) 152-158
11. Smeets S.J., Hesselink A.T., Speel E.J., et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121 11 (2007) 2465-2472
12. Hafkamp H.C., Speel E.J., Haesevoets A., et al. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8. Int J Cancer 107 3 (2003) 394-400
13. Steenbergen R.D., Hermsen M.A., Walboomers J.M., et al. Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res 55 22 (1995) 5465-5471
14. Wiest T., Schwarz E., Enders C., et al. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 21 10 (2002) 1510-1517
15. Wilczynski S.P., Lin B.T., Xie Y., et al. Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol 152 1 (1998) 145-156
16. van Houten V.M., Snijders P.J., van den Brekel M.W., et al. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 93 2 (2001) 232-235
17. Ke L.D., Adler-Storthz K., Mitchell M.F., et al. Expression of human papillomavirus E7 mRNA in human oral and cervical neoplasia and cell lines. Oral Oncol 35 4 (1999) 415-420
18. Balz V., Scheckenbach K., Gotte K., et al. Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens. Cancer Res 63 6 (2003) 1188-1191
19. Braakhuis B.J., Snijders P.J., Keune W.J., et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 96 13 (2004) 998-1006
20. Schwartz S.M., Daling J.R., Doody D.R., et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 90 21 (1998) 1626-1636
21. Andl T., Kahn T., Pfuhl A., et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 58 1 (1998) 5-13
22. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 200112;344(15):1125-31.
23. Gillison M.L. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 31 6 (2004) 744-754
24. Mellin H., Friesland S., Lewensohn R., et al. Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer 89 3 (2000) 300-304
25. Sisk E.A., Soltys S.G., Zhu S., et al. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma. Head Neck 24 9 (2002) 841-849
26. Cruz I.B., Snijders P.J., Steenbergen R.D., et al. Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas. Eur J Cancer B Oral Oncol 32B 1 (1996) 55-62
27. Ringstrom E., Peters E., Hasegawa M., et al. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 8 10 (2002) 3187-3192
28. Strome S.E., Savva A., Brissett A.E., et al. Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res 8 4 (2002) 1093-1100
29. Ragin C.C., and Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta-analysis. Int J Cancer 121 8 (2007) 1813-1820
30. Fakhry C., Westra W.H., Li S., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100 4 (2008) 261-269
31. Kreimer A.R., Clifford G.M., Boyle P., et al. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14 2 (2005) 467-475
32. Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 32 Suppl 1 (2005) S59-S66
33. Syrjanen S. HPV infections and tonsillar carcinoma. J Clin Pathol 57 5 (2004) 449-455
34. Herrero R, Catellsague X, Munoz N, et al. Multicentric case-control study of HPV and oral cancer. 20th International Papillomavirus Conference, October 4-9; Paris, France, 2002: 66.
35. Human Papillomavirus. IACR Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC WHO Press. 2007;90.
36. Fakhry C., and Gillison M.L. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 24 17 (2006) 2606-2611
37. Smith E.M., Ritchie J.M., Pawlita M., et al. Human papillomavirus seropositivity and risks of head and neck cancer. Int J Cancer 120 4 (2007) 825-832
38. Pintos J., Black M.J., Sadeghi N., et al. Human papillomavirus infection and oral cancer: A case-control study in Montreal, Canada. Oral Oncol 44 (2008) 242-250
39. Furniss C.S., McClean M.D., Smith J.F., et al. Human papillomavirus 16 and head and neck squamous cell carcinoma. Int J Cancer 120 11 (2007) 2386-2392
40. Dahlstrom K.R., Adler-Storthz K., Etzel C.J., et al. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res 9 7 (2003) 2620-2626
41. Herrero R., Castellsague X., Pawlita M., et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95 23 (2003) 1772-1783
42. D'Souza G., Kreimer A.R., Viscidi R., et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356 10 (2007) 1944-1956
43. Tindle R.W. Immune evasion in human papillomavirus-associated cervical cancer. Nat Rev 2 1 (2002) 59-65
44. Stanley M., Lowy D.R., and Frazer I. Chapter 12: prophylactic HPV vaccines: underlying mechanisms. Vaccine 24 Suppl 3 (2006) S106-S113
45. Viscidi R.P., Schiffman M., Hildesheim A., et al. Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica. Cancer Epidemiol Biomarkers Prev 13 2 (2004) 324-327
46. Hansson B.G., Rosenquist K., Antonsson A., et al. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Oto-laryngol 125 12 (2005) 1337-1344
47. Smith E.M., Ritchie J.M., Summersgill K.F., et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 96 6 (2004) 449-455
48. Gillison M., D'Souza G., Westra W., et al. Distinct risk factor profiles for human papillomaviurs type 16-positive and human papillomavirus 16-negative head and neck cancers. J Natl Cancer Inst 100 6 (2008) 408-420
49. Ault K.A. Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect Dis Obstet Gynecol 2006 Suppl (2006) 40470
50. Syrjanen S., and Puranen M. Human papillomavirus infections in children: the potential role of maternal transmission. Crit Rev Oral Biol Med 11 2 (2000) 259-274
51. Silverberg M.J., Thorsen P., Lindeberg H., et al. Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol 101 4 (2003) 645-652
52. Watts D.H., Koutsky L.A., Holmes K.K., et al. Low risk of perinatal transmission of human papillomavirus: results from a prospective cohort study. Am J Obstet Gynecol 178 2 (1998) 365-373
53. Smith E.M., Ritchie J.M., Yankowitz J., et al. Human papillomavirus prevalence and types in newborns and parents: concordance and modes of transmission. Sex Transm Dis 31 1 (2004) 57-62
54. Rice P.S., Cason J., Best J.M., et al. High risk genital papillomavirus infections are spread vertically. Rev Med Virol 9 1 (1999) 15-21
55. Dillner J., Andersson-Ellstrom A., Hagmar B., et al. High risk genital papillomavirus infections are not spread vertically. Rev Med Virol 9 1 (1999) 23-29
56. Smith E.M., Swarnavel S., Ritchie J.M., et al. Prevalence of human papillomavirus in the oral cavity/oropharynx in a large population of children and adolescents. Pediatr Infect Dis J 26 9 (2007) 836-840
57. Kreimer A.R., Alberg A.J., Daniel R., et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis 189 4 (2004) 686-698
58. Smith E.M., Hoffman H.T., Summersgill K.S., et al. Human papillomavirus and risk of oral cancer. Laryngoscope 108 7 (1998) 1098-1103
59. Coutlee F., Trottier A.M., Ghattas G., et al. Risk factors for oral human papillomavirus in adults infected and not infected with human immunodeficiency virus. Sex Transm Dis 24 1 (1997) 23-31
60. do Sacramento P.R., Babeto E., Colombo J., et al. The prevalence of human papillomavirus in the oropharynx in healthy individuals in a Brazilian population. J Med Virol 78 5 (2006) 614-618
61. Fakhry C., D'Souza G., Sugar E., et al. Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women. J Clin Microbiol 44 12 (2006) 4479-4485
62. Rose B., Wilkins D., Li W., et al. Human papillomavirus in the oral cavity of patients with and without renal transplantation. Transplantation 82 4 (2006) 570-573
63. Giraldo P., Goncalves A.K., Pereira S.A., et al. Human papillomavirus in the oral mucosa of women with genital human papillomavirus lesions. Eur J Obstet Gynecol Reprod Biol 126 1 (2006) 104-106
64. Ritchie J.M., Smith E.M., Summersgill K.F., et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 104 3 (2003) 336-344
65. Smith E.M., Ritchie J.M., Summersgill K.F., et al. Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer 108 5 (2004) 766-772
66. Suzich J.A., Ghim S.J., Palmer-Hill F.J., et al. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci USA 92 25 (1995) 11553-11557
67. Brandtzaeg P. Do salivary antibodies reliably reflect both mucosal and systemic immunity?. Ann N Y Acad Sci 1098 (2007) 288-311
68. Cameron J.E., Snowhite I.V., Chaturvedi A.K., et al. Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals. Clin Diagn Lab Immunol 10 3 (2003) 431-438
69. Buchinsky F.J., Carter J.J., Wipf G.C., et al. Comparison of oral fluid and serum ELISAs in the determination of IgG response to natural human papillomavirus infection in university women. J Clin Virol 35 4 (2006) 450-453
70. Marais D.J., Best J.M., Rose R.C., et al. Oral antibodies to human papillomavirus type 16 in women with cervical neoplasia. J Med Virol 65 1 (2001) 149-154
71. Passmore J.A., Marais D.J., Sampson C., et al. Cervicovaginal, oral, and serum IgG and IgA responses to human papillomavirus type 16 in women with cervical intraepithelial neoplasia. J Med Virol 79 9 (2007) 1375-1380
72. Marais D.J., Sampson C., Jeftha A., et al. More men than women make mucosal IgA antibodies to human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population. BMC Infect Dis 6 (2006) 95
73. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007;356(19):1915-27.
74. Paavonen J., Jenkins D., Bosch F.X., et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369 9580 (2007) 2161-2170
75. Reisinger K.S., Block S.L., Lazcano-Ponce E., et al. Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial. Pediatr Infect Dis J 26 3 (2007) 201-209
76. Clifford G.M., Smith J.S., Plummer M., et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88 1 (2003) 63-73
77. Smith J.S., Lindsay L., Hoots B., et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121 3 (2007) 621-632
78. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118 12 (2006) 3030-3044
79. Li W., Tran N., Lee S.C., et al. New evidence for geographic variation in the role of human papillomavirus in tonsillar carcinogenesis. Pathology 39 2 (2007) 217-222
80. Ryerson A., Peters E., Coughlin S., et al. Burden of potentially HPV-associated cancers of the oropharynx and oral cavity in the United States. 1998-2003. Cancer (2008) in press
81. Frisch M., Hjalgrim H., Jaeger A.B., et al. Changing patterns of tonsillar squamous cell carcinoma in the United States. Cancer Causes Control 11 6 (2000) 489-495
82. Shiboski C.H., Schmidt B.L., and Jordan R.C. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 103 9 (2005) 1843-1849
83. Golas S.M. Trends in palatine tonsillar cancer incidence and mortality rates in the United States. Community Dent Oral Epidemiol 35 2 (2007) 98-108
84. Chaturvedi A., Engels E., Anderson W., et al. Incidence trends for human papillomavirus-related (HPV-R) and unrelated (HPV-U) head and neck squamous cell carcinomas (HNSCC) in the United States (US). J Clin Oncol 25 18S (2007) 299s
85. Hammarstedt L., Dahlstrand H., Lindquist D., et al. The incidence of tonsillar cancer in Sweden is increasing. Acta Oto-laryngologica 127 9 (2007) 988-992
86. Sturgis E.M., and Cinciripini P.M. Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?. Cancer 110 7 (2007) 1429-1435
87. D'Souza G., Fakhry C., Sugar E.A., et al. Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer 121 1 (2007) 143-150
88. Evans B.A., McCormack S.M., Kell P.D., et al. Trends in female sexual behaviour and sexually transmitted diseases in London, 1982-1992. Genitourin Med 71 5 (1995) 286-290
89. Gagnon J.H., and Simon W. The sexual scripting of oral genital contacts. Arch Sex Behav 16 1 (1987) 1-25
90. Edwards S., and Carne C. Oral sex and the transmission of viral STIs. Sex Transm Infect 74 1 (1998) 6-10
91. Edwards S., and Carne C. Oral sex and transmission of non-viral STIs. Sex Transm Infect 74 2 (1998) 95-100
92. Halpern-Felsher B.L., Cornell J.L., Kropp R.Y., et al. Oral versus vaginal sex among adolescents: perceptions, attitudes, and behavior. Pediatrics 115 4 (2005) 845-851
93. Prinstein M.J., Meade C.S., and Cohen G.L. Adolescent oral sex, peer popularity, and perceptions of best friends' sexual behavior. J Pediatr Psychol 28 4 (2003) 243-249
94. Mosher W.D., Chandra A., and Jones J. Sexual behavior and selected health measures: men and women 15-44 years of age, United States, 2002. Adv Data 15 362 (2005) 1-55
95. Stone N., Hatherall B., Ingham R., et al. Oral sex and condom use among young people in the United Kingdom. Perspect Sex Reprod Health 38 1 (2006) 6-12
96. Trends in HIV-related risk behaviors among high school students-United States, 1991-2005. MMWR 55 31 (2006) 851-854
97. Rissel C.E., Richters J., Grulich A.E., et al. Sex in Australia: first experiences of vaginal intercourse and oral sex among a representative sample of adults. Aust N Z J Public Health 27 2 (2003) 131-137
98. Oliver M.B., and Hyde J.S. Gender differences in sexuality: a meta-analysis. Psychol Bull 114 1 (1993) 29-51
99. Ompad D.C., Strathdee S.A., Celentano D.D., et al. Predictors of early initiation of vaginal and oral sex among urban young adults in Baltimore, Maryland. Arch Sex Behav 35 1 (2006) 53-65